Nucleus Formulation Private Limited, a active private limited company, was established on 13 July 2009 in Chhatral, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GJ2009PTC057517. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 13 professional, Its leadership includes Jitendra Lavjibhai Patel (Director), Dipesh Jyotindrakumar Thakar (Director). Past directors included Sureshbhai Kadavabhai Patel, Jayesh Sharadchandra Pandya. It holds ₹2.57 Cr open charges and ₹5.83 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 3484 Ph-4 Gidc Chhatral, Tal Kalol, Chhatral, Gujarat, 382729.
U24239GJ2009PTC057517
057517
13 July 2009
₹5.00 M
₹5.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nucleus Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendra Lavjibhai Patel | Director | 13 Jul 2009 | Current |
| Dipesh Jyotindrakumar Thakar | Director | 13 Jul 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Oct 2015 | Past |
| Pramod Abcsdd | Director | 20 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nucleus Formulation Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 25.66% decrease. The company also saw a substantial fall in profitability, with a 39.83% decrease in profit. The company's net worth moved up by a moderate rise of 8.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nucleus Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹25,660,000.00
₹58,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2023 | Sidbi | ₹5.26 M | Open |
| 06 Jun 2023 | Others | ₹2.00 Cr | Open |
| 24 Jun 2021 | Hdfc Bank Limited | ₹0.40 M | Open |
| 11 Apr 2019 | Others | ₹2.50 Cr | Satisfied |
| 09 Oct 2014 | Hdfc Bank Limited | ₹1.36 Cr | Satisfied |
Explore comprehensive loan charge details -
Nucleus Formulation has a workforce of 13 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nucleus Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nucleus Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Nucleus Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity A charge with Sidbi amounted to Rs. 5.26 M with Charge ID 100755911 was registered on 28 Jul 2023. was completed.
A charge registered on 11 Apr 2019 via Charge ID 100259131 with Others was fully satisfied on 30 Jun 2023. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 20.00 M with Charge ID 100746083 was registered on 06 Jun 2023. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.40 M with Charge ID 100465568 was registered on 24 Jun 2021. was completed.
The CIN of Nucleus Formulation Private Limited is U24239GJ2009PTC057517.
Nucleus Formulation Private Limited is headquartered at Plot No 3484 Ph-4 Gidc Chhatral, Tal Kalol, Chhatral, Gujarat, 382729.
Nucleus Formulation Private Limited was incorporated on 13 July 2009.
The current directors of Nucleus Formulation Private Limited are
The primary industry of Nucleus Formulation Private Limited is Manufacturing.
Nucleus Formulation Private Limited is unlisted.
The authorized capital of Nucleus Formulation Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Nucleus Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX